🔎 Trials Near Me

Domov › Prekomerna telesna teža › Texas › San Antonio

Klinične študije za Prekomerna telesna teža v San Antonio, TX

34 študij za Prekomerna telesna teža išče udeležence na lokacijah v San Antonio in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
  • Kailera Clinical Site, San Antonio
Starost 18–85 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07793929

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Vključevanje udeležencevFaza 3
  • DM Clinical, San Antonio
  • The Texas Liver Institute, San Antonio
  • Pinnacle Clinical Research, San Antonio
  • in še 1
Starost 8–18 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07253285

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Vključevanje udeležencevFaza 1
  • Endeavor Clinical Trials, San Antonio
Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Vključevanje udeležencevFaza 3
  • Sleep Therapy Research Center, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Vključevanje udeležencevFaza 3
  • IMA Clinical Research San Antonio, San Antonio
  • VIP Trials, San Antonio, TX 78230
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Vključevanje udeležencevFaza 3
  • VIP Trials, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Vključevanje udeležencevFaza 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • IMA Clinical Research San Antonio, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3
  • IMA Clinical Research San Antonio, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Sleep Therapy Research Center, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Bandera Family Health Care, San Antonio
  • Consano Clinical Research - Shavano Park, Shavano Park · 12 mi stran
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • IMA Clinical Research San Antonio, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • VIP Trials, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • Endeavor Clinical Trials, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 3
  • AURORA-1 Clinical Site, San Antonio
  • AURORA-1 Clinical Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Vključevanje udeležencevFaza 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Pinnacle Clinical Research - South San Antonio, San Antonio
  • IMA Clinical Research - San Antonio, San Antonio
  • Consano Clinical Research, Shavano Park · 12 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351045

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3
  • Sleep Therapy Research Center, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
  • ACCOMPLISH-2 Research Site, San Antonio
  • ACCOMPLISH-2 Research Site, San Antonio
Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3
  • Sleep Therapy Research Center, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • Endeavor Clinical Trials, San Antonio
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
  • ICON, San Antonio
Starost 18–55 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07767175

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Vključevanje udeležencevFaza 4
  • Texas Dermatology and Laser Specialists, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • Clinical Trials of Texas, San Antonio
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
  • ICON Early Phase Services, LLC, San Antonio
Starost 18–65 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07654972

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Vključevanje udeležencevFaza 3
  • VIP Trials, San Antonio
Starost 18–99 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, San Antonio
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07784725

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
  • ICON Early Phase Services, San Antonio
Starost 18–65 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07738614

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Vključevanje udeležencevFaza 3
  • ACCOMPLISH-1 Research Site, San Antonio
Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

Študije za Prekomerna telesna teža v drugih mestih

Druge študije v San Antonio

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.